Immutable evidence record · ticker
Neurocrine Biosciences, Inc. (N1BI34)
Published as observed on 18 August 2026 at 01:03 BST.
Neurocrine Biosciences, Inc. has a balanced company news read. Its latest completed weekly trend is positive.
- As of
- 18 Aug 2026, 01:03
- Scope
- company and instrument
- Evidence
- 15 items
- Independent sources
- 2
- Country
- Brazil
- Sector
- Healthcare
- Previous read
- 54.000
- Change
- -1.000
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Neurocrine Biosciences, Inc. (N1BI34), 2026-08-18, https://sharemaestro.com/evidence/4da771f6-95ca-4abf-a3ce-3813033c37c1/
Record checksum 784cf05822fe2d1baea67cd80d83b19771629afd6921182f0678e1250d21e9a4
